Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality

Journal of the American Society of Hypertension

Volumn 8, Issue 6, 2014, Pages 405-413

  Irvin, Marguerite R ^a   Booth III, John N ^a   Shimbo, Daichi ^b   Lackland, Daniel T ^c   Oparil, Suzanne ^d   Howard, George ^a   Safford, Monika M ^e   Muntner, Paul ^a   Calhoun, David A ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

antihypertensives; outcomes; Resistant hypertension; severe hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTIHYPERTENSIVE THERAPY; APPARENT TREATMENT RESISTANT HYPERTENSION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DIURETIC THERAPY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RESISTANT HYPERTENSION; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; CORONARY DISEASE; DRUG EFFECTS; HYPERTENSION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAUSE OF DEATH; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; UNITED STATES;

EID: 84903215816     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.03.003     Document Type: Article

References (35)

1. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 e510 e526
2. B.M. Egan, Y. Zhao, R.N. Axon, W.A. Brzezinski, and K.C. Ferdinand Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008 Circulation 124 2011 1046 1058
3. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
4. A. de la Sierra, J. Segura, J.R. Banegas, M. Gorostidi, J.J. de la Cruz, and P. Armario et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
5. M.R. Irvin, D. Shimbo, D.M. Mann, K. Reynolds, M. Krousel-Wood, and N.A. Limdi et al. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension J Clin Hypertens (Greenwich) 14 2012 694 700
6. J.G. Wang, and J.A. Staessen Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials J Clin Hypertens (Greenwich) 5 2003 66 75
7. J. He, and P.K. Whelton Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials Am Heart J 138 1999 211 219
8. F. Turnbull, B. Neal, T. Ninomiya, C. Algert, H. Arima, and F. Barzi et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 2008 1121 1123
9. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlöf, D. Elmfeldt, and S. Julius et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 351 1998 1755 1762
10. H.T. Ong Cardiovascular outcomes in the comparative hypertension drug trials: more consensus than controversy Singapore Med J 49 2008 599 605 quiz 606
11. V.J. Howard, M. Cushman, L. Pulley, C.R. Gomez, R.C. Go, and R.J. Prineas et al. The reasons for geographic and racial differences in stroke study: objectives and design Neuroepidemiology 25 2005 135 143
12. D.E. Morisky, L.W. Green, and D.M. Levine Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 24 1986 67 74
13. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro, and H.I. Feldman et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
14. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
15. J.F. Meschia, T.G. Brott, F.E. Chukwudelunzu, J. Hardy, R.D. Brown, and I. Meissner et al. Verifying the stroke-free phenotype by structured telephone interview Stroke 31 2000 1076 1080
16. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders Stroke 20 1989 1407 1431
17. E.Z. Soliman, G. Howard, M. Cushman, B. Kissela, D. Kleindorfer, and A. Le et al. Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study J Am Coll Cardiol 59 2012 1460 1467
18. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, and M. Galvani et al. Universal definition of myocardial infarction Circulation 116 2007 2634 2653
19. R.V. Luepker, F.S. Apple, R.H. Christenson, R.S. Crow, S.P. Fortmann, and D. Goff et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 2003 2543 2549
20. R. Prineas, R. Crow, and H. Blackburn The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification 1982 Wright-OSG Boston, MA
21. R. Prineas, R. Crow, and Z.-M. Zhang Minnesota code Manual of Electrocardiographich Findings 2nd ed. 2010 Springer-Verlag London
22. E. Pimenta, and D.A. Calhoun Resistant hypertension: incidence, prevalence, and prognosis Circulation 125 2012 1594 1596
23. S.L. Daugherty, J.D. Powers, D.J. Magid, H.M. Tavel, F.A. Masoudi, and K.L. Margolis et al. Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
24. D.J. Kumbhani, P.G. Steg, C.P. Cannon, K.A. Eagle, S.C. Smith, and K. Crowley et al. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis Eur Heart J 34 2013 1204 1214
25. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins, and Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
26. W.B. Kannel, P.A. Wolf, J. Verter, and P.M. McNamara Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study JAMA 214 1970 301 310
27. R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Fiebach, and K.A. Eberlein et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 838
28. C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, and R. Lapenna et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment Arch Intern Med 168 2008 80 85
29. P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, and J.J. Mourad Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J Am Coll Cardiol 45 2005 1243 1248
30. J.M. Marin, S.J. Carrizo, E. Vicente, and A.G. Agusti Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study Lancet 365 2005 1046 1053
31. G.F. Mitchell, S.J. Hwang, R.S. Vasan, M.G. Larson, M.J. Pencina, and N.M. Hamburg et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study Circulation 121 2010 505 511
32. W.B. Kannel, C. Kannel, R.S. Paffenbarger, and L.A. Cupples Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1987 1489 1494
33. L. Paul, C.E. Hastie, W.S. Li, C. Harrow, S. Muir, and J.M. Connell et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients Hypertension 55 2010 567 574
34. K.J. Rothman, and S. Greenland Modern Epidemiology 2nd ed. 1998 Lippincott Williams & Wilkins Philadelphia
35. E.F. Schisterman, S.R. Cole, and R.W. Platt Overadjustment bias and unnecessary adjustment in epidemiologic studies Epidemiology 20 2009 488 495